Page last updated: 2024-08-23

bm 13505 and kw 3635

bm 13505 has been researched along with kw 3635 in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishii, A; Kase, H; Miki, I1
Higo, K; Karasawa, A; Kubo, K; Shirakura, S1
Karasawa, A; Kubo, K; Shirakura, S1
Ishii, A; Karasawa, A; Kawakage, M; Kubo, K; Miki, I; Shirakura, S; Takeda, M1
Higo, K; Karasawa, A; Kawakage, M; Kubo, K; Obase, H; Ohshima, E; Shirakura, S1
Higo, K; Karasawa, A; Shirakura, S; Takeda, M1
Higo, K; Karasawa, A1
Ishihara, N; Karasawa, A; Kase, H; Kawakage, M1

Other Studies

8 other study(ies) available for bm 13505 and kw 3635

ArticleYear
Differences in activities of thromboxane A2 receptor antagonists in smooth muscle cells.
    European journal of pharmacology, 1992, Oct-01, Volume: 227, Issue:2

    Topics: Animals; Benzimidazoles; Benzoxepins; Binding Sites; Bridged Bicyclo Compounds, Heterocyclic; Calcium; Cells, Cultured; Fatty Acids, Unsaturated; Hydrazines; Male; Muscle, Smooth, Vascular; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Wistar; Receptors, Prostaglandin; Receptors, Thromboxane; Receptors, Thromboxane A2, Prostaglandin H2; Sulfonamides; Thromboxane A2

1992
Actions of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-1-carboxylate monohydrate on smooth muscle preparations.
    Arzneimittel-Forschung, 1991, Volume: 41, Issue:12

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Benzimidazoles; Benzoxepins; Blood Pressure; Cats; Dogs; Female; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; Phenylacetates; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Rabbits; Rats; Rats, Inbred Strains; Species Specificity; Sulfonamides; Thromboxane A2

1991
Protective effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate against 9,11-dideoxy- 9 alpha, 11 alpha-epoxymethano-prostaglandin F2
    Arzneimittel-Forschung, 1991, Volume: 41, Issue:12

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aspirin; Benzimidazoles; Benzoxepins; Blood Pressure; Death, Sudden; Dose-Response Relationship, Drug; Guinea Pigs; Male; Phenylacetates; Platelet Aggregation Inhibitors; Platelet Count; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Sulfonamides; Thromboxane A2; Thromboxanes; Ticlopidine

1991
Beneficial effect of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)ethylidene]-6,11- dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate on collagen-induced coronary ischemia in guinea-pigs.
    Arzneimittel-Forschung, 1991, Volume: 41, Issue:12

    Topics: Animals; Arrhythmias, Cardiac; Benzimidazoles; Benzoxepins; Collagen; Coronary Disease; Cyclooxygenase Inhibitors; Electrocardiography; Guinea Pigs; Heart Arrest; Male; Nifedipine; Phenylacetates; Propranolol; Sulfonamides; Thromboxane A2; Thromboxane B2; Thromboxanes; Ticlopidine

1991
Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
    Arzneimittel-Forschung, 1991, Volume: 41, Issue:12

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Triphosphate; Adult; Animals; Benzimidazoles; Benzoxepins; Cats; Dogs; Drug Interactions; Epinephrine; Guinea Pigs; Humans; In Vitro Techniques; Mice; Middle Aged; Phenylacetates; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Prostaglandins; Rabbits; Rats; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxane A2

1991
Antithrombotic effects of KW-3635, a thromboxane A2-receptor antagonist, in guinea pigs.
    Japanese journal of pharmacology, 1994, Volume: 65, Issue:2

    Topics: Animals; Arterial Occlusive Diseases; Aspirin; Benzimidazoles; Benzoxepins; Blood Coagulation; Blood Platelets; Disease Models, Animal; Erythrocyte Count; Femoral Artery; Guinea Pigs; Lauric Acids; Male; Phenylacetates; Platelet Count; Sulfonamides; Thrombosis; Thromboxane A2; Thromboxanes; Ticlopidine

1994
Inhibitory effect of KW-3635, a new thromboxane A2-receptor antagonist, on arterial thrombosis in guinea pigs.
    Japanese journal of pharmacology, 1993, Volume: 63, Issue:4

    Topics: Animals; Arachidonic Acid; Aspirin; Benzimidazoles; Benzoxepins; Collagen; Disease Models, Animal; Femoral Artery; Guinea Pigs; Male; Phenylacetates; Platelet Aggregation; Sulfonamides; Thrombosis; Thromboxane A2

1993
[Effects of KW-3635 on the diuretic action of furosemide in rats].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1993, Volume: 101, Issue:1

    Topics: Administration, Oral; Animals; Benzimidazoles; Benzoxepins; Diuresis; Drug Synergism; Electrolytes; Furosemide; Male; Phenylacetates; Rats; Rats, Wistar; Sulfonamides; Thromboxane A2

1993